Disposable Medical Supplies Markets

This Publications report is intended to provide basic marketing data pertaining to the U.S. and worldwide market segments of the disposable medical supplies market, including: surgical gowns, surgical drapes, isolation gowns, surgical and examination gloves, institutional incontinence disposables, operating room (OR) custom kits and trays, non-OR custom packs, shoe covers, masks, disposable coveralls and lab coats, headwear, protective eyewear, sterile wipes, swabs and mops. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Growth rates and sales projections are reported in units and U.S. dollars. Market shares are based on units and apply to the U.S. only.

Table of Contents :

1. Introduction 10
1.1 Objectives 10
1.2 Scope 10
1.3 Methodology 11
1.4 Executive Summary 12

2. Disposable Medical Supplies Market 14
2.1 Overview 14
2.2 Technological Advancements in Disposable Medical Supplies 14

3. Nanotechnology in Medical Devices and Disposables 15
3.1 Implants 16
3.2 Tissue Engineering 16
3.3 Sensors 16
3.4 Stents 16
3.5 Nanostructured TiOx Ultra Thin Films 16
3.6 Drug Delivery 17
3.7 Heat Therapy 17
3.8 MRI/X-ray 17
3.9 Bone Cement 17

4. Medical Design Excellence Awards for Medical Disposables 18
4.1 Winning Disposable Medical Products and Suppliers, 2008 18
4.1.1 HemCon® Bandage 18
4.1.2 Veramyst™ (Fluticasone Furoate) Nasal Spray Delivery Device 19
4.1.3 Akreos® AO Microincision Lens, Model MI60 19
4.1.4 GeeWhiz Male External Condom Catheter 19
4.1.5 Natural Nurser™ Baby Bottle 20
4.1.6 NovoFine® Autocover™ Automatic Safety Pen Needle 20
4.1.7 Uresta™ Continence Care Kit 20
4.1.8 InteguSeal™ Microbial Sealant 21
4.1.9 Patient Registration Mask 21
4.2 Winning Disposable Medical Products and Suppliers in 2007 21
4.2.1 Thermoplastic Drill Template Set 21
4.2.2 Ospol Dental Implant System Packaging 22
4.2.3 Episure™ AutoDetect Epidural Syringe 22
4.2.4 Odor Absorbing Hydrocolloid Wound Dressing 23
4.2.5 SureSkin® Central Catheter and I.V. Dressing 23
4.2.6 Gynecare TVT Secur™ System for Treating Stress Urinary Incontinence 23
4.2.7 Conveen® Optima Silicone Urisheath 24
4.3 Winning Disposable Medical Products and Suppliers, 2006 24
4.3.1 eFlow® Electronic Nebulizer 24
4.4 Winning Disposable Medical Products and Suppliers, 2005 24
4.4.1 OptraGate® 24
4.4.2 RelyX™ Luting Plus Cement 25
4.4.3 3M™ Foam Adhesive Dressing 25
4.4.4 ClozeX Wound Closure Device 25

http://www.aarkstore.com/reports/Disposable-Medical-Supplies-Markets-1507.html

Nanosys Announces Promising Results With Its Gecko-Inspired Drug Delivery Device

Nanosys, Inc. announced today the results of their initial studies using a novel silicon nanowire mucous membrane drug delivery device. These devices have a nano-structured surface that relies on adhesive properties known in physics as van der Waals forces of adhesion. Results of initial studies published this week in the American Chemical Society’s Nano Letters, outline the device’s ability to significantly improve drug delivery to mucous membranes such as those in the nose, intestine, eyes, vagina and mouth.

Mucous membranes have long been a target for drug delivery due to their large surface area and rich blood supply. However, nature has designed these membranes to also be efficient barriers to foreign substance penetration, such as drugs. Mucus, which is constantly produced by these tissues, is moved across the surface by tiny beating hair-like structures called cilia. Removal of a substance floating in the mucus of the nasal cavity can be as fast as ten minutes, for example. Previous attempts at overcoming this barrier function relied on chemical modification of the delivery vehicle to better adhere to binding elements within the mucus. Nanosys’s silicon nanowires will adhere instead to the cells underneath the mucus, the actual targets for drug delivery. This critical feature allows for a longer residence time, improved local concentrations and better absorption of target drugs by the tissues.

The team, led by Hugh Daniels at Nanosys and Tejal Desai and Kayte Fischer at the University of California, San Francisco, also quantified the amount of mucosal shear force the silicon nanowire-based devices could withstand before being eliminated, and demonstrated it to be at least 100-fold better than a non-silicon nanowire device.

“In the near term, there are a lot of chronic conditions of the nose, sinuses and other tissues that could immediately benefit from more efficient delivery of currently available drugs using our silicon nanowire drug delivery technology. We are also excited about the longer term potential of delivery of systemic drugs such as insulin via the mucous membrane route,” said Dr. Daniels. In addition, silicon nanowires are inexpensive to make and are biocompatible. Nanosys expects to develop the technology further in partnership with drug manufacturers whose drugs could be made more effective through this delivery approach.

About Nanosys, Inc.

Nanosys, Inc. is a leader in the development of nanotechnology-enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 650 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense. Additional information on Nanosys can be found on its website at www.nanosysinc.com.